Open an Account
search icon
2
NOTIFICATIONS
Best Algo trading app in India

Back Stocks profile

Stock analysis tool for investors

Abbott India Ltd.

NSE: ABBOTINDIA | BSE:500488

₹27768.10 153.20 (0.55%) 1D

Pharmaceuticals & Biotechnology

Buy Sell
View detailed Technical chart

Open an Account with Bigul in 5 minutes

Performance

Today’s low

27623.20

Today’s High

27839.40

52W low

22000.00

52W High

29639.00

Open Price

27700.00

Prev. Close

26998.8000

Volume

2437.00

Value

67670859.70

Fundamentals

Market Cap Cr

59005.30

Price to Earnings

49.10

Price to Book Value

16.00

Dividend Yield

1.20

PE to Growth

1.90

Op Revenue TTM Cr

5848.91

Net Profit TTM Cr

1201.22

Cash From Operating Activity Cr

1212.81

Return on Equity %

32.47

EMA & SMA

Bullish Moving Averages

16

Bearish Moving Averages

0

5Day EMA

27506.8

10Day EMA

27376.5

12Day EMA

27336.4

20Day EMA

27191.2

26Day EMA

27103

50Day EMA

26909.4

100Day EMA

26556.4

200Day EMA

25603.3

5Day SMA

27576.2

10Day SMA

27223.7

20Day SMA

27312.6

30Day SMA

26911.8

50Day SMA

26625.6

100Day SMA

27196.4

150Day SMA

26170.8

200Day SMA

25368.2

DELIVERY AND VOLUME

DAILY AVG. DELIVERY VOLUME %

02 Jul, 2024

25.3

Week

44.1

Month

45.2

LEGEND

Positive Indicator

Neutral Indicator

Negative Indicator

RESISTANCE AND SUPPORT

27758.62

PIVOT

First Resistance

27955.28

Second Resistance

28295.67

Third Resistance

28492.33

First Support

27418.23

Second Support

27221.57

Third Support

26881.18

Relative Strength Index

58.98

Money Flow Index

65.7

MACD

233.4

MACD Signal

208.41

Average True Range

535.73

Average Directional Index

23.75

Rate of Change (21)

6.67

Rate of Change (125)

20.85

Commodity Channel Index

80.2

Williams %R

-45.2

BETA

1 Month

0.13

3 Month

0.27

1 Year

0.26

3 Year

0.1

PRICE CHANGE ANALYSIS

↑ 3.4%

1 Week

Low

High

26855.65

28099

↑ 7.26%

1 Month

Low

High

25588.55

28450

↑ 1.78%

3 Months

Low

High

25200

28450

↑ 19.04%

6 Months

Low

High

23143.55

29638.95

↑ 18.57%

1 Year

Low

High

22000

29638.95

Indicator Mar 2024 Dec 2023 Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022 Dec 2021 Sep 2021 Graph
Total Qtr Revenue cr 1519.78 1492.75 1549.65 1535.00 1392.72 1366.42 1413.01 1330.73 1276.07 1243.10 1240.27
Operating Expenses Qtr 1109.10 1049.45 1113.26 1124.00 1062.96 1009.99 1036.18 1033.97 961.20 955.30 962.37
Operating Profit Qtr 329.53 387.69 380.88 355.00 280.12 316.49 343.30 270.40 293.82 269.06 259.69
EBIDT Qtr Cr 410.68 443.30 436.39 411.00 329.76 356.43 376.83 296.76 314.87 287.80 277.90
Depreciation Qtr 18.19 17.97 17.84 17.17 17.34 17.81 17.47 17.35 17.43 16.74 16.20
Net Profit Qtr 287.06 310.98 312.94 290.24 231.42 246.83 265.52 205.64 211.41 199.20 192.33
Basic EPS Qtr 135.09 146.34 147.27 136.58 108.90 116.16 124.95 96.77 99.49 93.74 90.51
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Total Revenue Annual 6097.18 5502.88 4996.48 4390.92 4207.53
Operating Expenses Annual Cr 4395.81 4143.10 3831.55 3388.56 3336.70
Operating Profit Annual 1453.10 1205.63 1087.72 921.46 756.45
Operating Profit Margin Annual % 23.83 21.91 21.77 20.99 17.98
Total Expenses Annual Cr 4479.43 4229.06 3916.75 3464.97 3404.84
EBIDT Annual Cr 1701.37 1359.78 1164.93 1002.36 870.83
EBIDT Annual margin % 27.90 24.71 23.32 22.83 20.70
Depreciation 71.17 69.97 66.10 58.13 59.61
PAT Before ExtraOrdinary Items Annual Cr 1201.22 949.41 798.70 690.69 592.93
Net Profit Annual 1201.22 949.41 798.70 690.69 592.93
Basic EPS Annual 565.28 446.78 375.86 325.04 279.04
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Total ShareHolders Funds Annual 3698.89 3188.54 2819.79 2602.16 2431.71
Minority Interest Liability Annual Cr - - - - -
Total Non Current Liabilities Annual Cr 151.88 160.95 201.14 207.43 224.04
Total Current Liabilities Annual Cr 1342.72 1206.02 1203.19 1030.86 891.10
Total Capital Plus Liabilities Annual Cr 5193.49 4555.51 4224.12 3840.45 3546.85
Fixed Assets Annual 235.05 240.57 271.66 251.44 271.47
Total Non Current Assets Annual 1947.65 1530.40 371.08 321.93 342.21
Total Current Assets Annual 3245.84 3025.11 3853.04 3518.52 3204.64
Total Assets Annual 5193.49 4555.51 4224.12 3840.45 3546.85
Contingent Liabilities plus Commitments Annual Cr - 106.06 123.78 123.51 110.98
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Cash from Operating Activity Annual 1212.81 893.39 947.66 726.74 626.11
Cash from Investing Activity Annual -416.03 -147.71 -395.84 -71.82 -401.19
Cash from Financing Annual Activity -744.71 -638.72 -637.38 -581.79 -216.79
Net Cash Flow Annual - 106.96 -85.56 73.13 8.13
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Book Value Per Share Annual 1740.65 1500.49 1326.96 1224.55 1144.37
ROE Annual % 32.47 29.77 28.32 26.54 24.38
ROCE Annual % 42.33 38.50 36.37 33.60 30.54
Total Debt to Total Equity Annual 0.00 0.00 0.00 0.00 0.00
EBDIT Annual Margin % 29.08 25.42 23.68 23.25 21.27
Indicator Graph
Total Qtr Revenue cr
Operating Expenses Qtr
Operating Profit Qtr
EBIDT Qtr Cr
Depreciation Qtr
Net Profit Qtr
Basic EPS Qtr
Indicator Graph
Total Revenue Annual
Operating Expenses Annual Cr
Operating Profit Annual
Operating Profit Margin Annual %
Total Expenses Annual Cr
EBIDT Annual Cr
EBIDT Annual margin %
Depreciation
PAT Before ExtraOrdinary Items Annual Cr
Net Profit Annual
Basic EPS Annual
Indicator Graph
Total ShareHolders Funds Annual
Minority Interest Liability Annual Cr
Total Non Current Liabilities Annual Cr
Total Current Liabilities Annual Cr
Total Capital Plus Liabilities Annual Cr
Fixed Assets Annual
Total Non Current Assets Annual
Total Current Assets Annual
Total Assets Annual
Contingent Liabilities plus Commitments Annual Cr
Indicator Graph
Cash from Operating Activity Annual
Cash from Investing Activity Annual
Cash from Financing Annual Activity
Net Cash Flow Annual
Indicator Graph
Book Value Per Share Annual
ROE Annual %
ROCE Annual %
Total Debt to Total Equity Annual
EBDIT Annual Margin %
Name Holding Percent Holding Id Pledged % Locked %
SBI NIFTY MIDCAP 150 INDEX FUND 1.88 74393489 - -
CANARA ROBECO MUTUAL FUND 1.25 74393490 - -
Name Holding Percent Holding Id Pledged % Locked %
ABBOTT CAPITAL INDIA LIMITED 50.44 74393484 0 0
ABBOTT HEALTHCARE PRODUCTS LIMITED 17.62 74393485 0 0
BRITISH COLLOIDS LIMITED 6.92 74393486 0 0
Name Holding Percent Holding Id
SBI NIFTY MIDCAP 150 INDEX FUND 1.88 74393489
CANARA ROBECO MUTUAL FUND 1.25 74393490
Name Holding Percent Holding Id
Ex-Date Dividend Amount Dividend Type Record Date Instrument Type
Jul 21, 2023 145 SPECIAL Jul 21, 2023 Equity Share
Jul 21, 2023 180 FINAL Jul 21, 2023 Equity Share
Aug 02, 2022 130 SPECIAL - Equity Share
Aug 02, 2022 145 FINAL - Equity Share
Jul 19, 2021 155 SPECIAL - Equity Share
Jul 19, 2021 120 FINAL - Equity Share
Aug 28, 2020 143 SPECIAL - Equity Share
Aug 28, 2020 107 FINAL - Equity Share
Aug 13, 2019 15 SPECIAL - Equity Share
Aug 13, 2019 50 FINAL - Equity Share
Jul 10, 2018 5 SPECIAL - Equity Share
Jul 10, 2018 50 FINAL - Equity Share
Jul 10, 2017 40 FINAL - Equity Share
Jul 08, 2016 35 FINAL - Equity Share
Jul 22, 2015 31 FINAL - Equity Share
Jul 23, 2014 23 FINAL - Equity Share
Apr 16, 2013 17 FINAL - Equity Share
May 04, 2012 17 FINAL - Equity Share
Apr 19, 2011 17 FINAL - Equity Share
Mar 03, 2010 17 FINAL - Equity Share
Mar 09, 2009 14 FINAL - Equity Share
Mar 28, 2008 17.5 FINAL - Equity Share
Apr 05, 2007 17.5 FINAL - Equity Share
Apr 21, 2006 17.5 FINAL - Equity Share
Apr 15, 2005 35 FINAL - Equity Share
Apr 16, 2004 35 FINAL - Equity Share
Apr 09, 2003 12 FINAL - Equity Share
Apr 08, 2002 - FINAL - Equity Share
May 21, 2001 - FINAL - Equity Share
Ex-Date Split Ratio Record Date
Ex-Date Purpose Notes
May 09, 2024 Audited Results & Final Dividend -
Feb 01, 2024 Quarterly Results -
Nov 09, 2023 Quarterly Results -
Aug 09, 2023 Quarterly Results -
May 19, 2023 Audited Results & Final Dividend -
Feb 10, 2023 Quarterly Results -
Nov 14, 2022 Quarterly Results -
Aug 10, 2022 Quarterly Results -
May 17, 2022 Audited Results & Dividend -
Feb 09, 2022 Quarterly Results -
Nov 12, 2021 Quarterly Results -
Aug 06, 2021 Quarterly Results -
May 18, 2021 Audited Results & Final Dividend -
Feb 09, 2021 Quarterly Results -
Nov 11, 2020 Quarterly Results -
Aug 07, 2020 Quarterly Results -
Jun 08, 2020 Audited Results & Dividend -
Feb 07, 2020 Quarterly Results -
Nov 12, 2019 Quarterly Results -
Aug 08, 2019 Quarterly Results -
May 27, 2019 Audited Results & Dividend -
Feb 08, 2019 Quarterly Results -
Nov 13, 2018 Quarterly Results -
Aug 13, 2018 Quarterly Results -
May 14, 2018 Audited Results & Dividend -
Feb 14, 2018 Quarterly Results -
Nov 13, 2017 Quarterly Results -
Aug 08, 2017 Quarterly Results -
May 19, 2017 Audited Results & Final Dividend -
Feb 06, 2017 Quarterly Results -
Nov 28, 2016 Quarterly Results -
Nov 22, 2016 Resignation of the Company Secretary -
Aug 26, 2016 Quarterly Results -
May 25, 2016 Audited Results & Final Dividend Appointment of new Registrar and Share Transfer Agent.
Feb 01, 2016 Quarterly Results -
Nov 06, 2015 Quarterly Results -
Aug 12, 2015 Quarterly Results -
May 27, 2015 Audited Results & Final Dividend -
Feb 10, 2015 Quarterly Results -
Nov 11, 2014 Quarterly Results -
May 28, 2014 Audited Results & Final Dividend Revised from 27/05/2014
Feb 08, 2014 Quarterly Results -
Aug 14, 2013 Quarterly Results -
Jun 03, 2013 Others To consider the sale and transfer of, or other appropriate restructuring of, the proprietary pharmaceuticals dIvision ("PPD") of the Company.
Apr 25, 2013 Quarterly Results -
Feb 20, 2013 Audited Results & Final Dividend -
Nov 10, 2012 Quarterly Results -
Aug 03, 2012 Quarterly Results -
May 14, 2012 Quarterly Results -
Mar 15, 2012 Appointment / Resignation of M.D The Board has appointed Mr. Rehan Khan as Managing Director of the Company w.e.f May 15, 2012 & accepted the resignation of Mr. Vivek Mohan as Managing Director of the Company w.e.f May 15, 2012.
Feb 28, 2012 Audited Results & Final Dividend The Board has recommended a Final Dividend of Rs. 17.00 per Equity Share of the face value Rs. 10 on 2,12,49,302 Equity Shares of the Company.
Nov 01, 2011 Quarterly Results -
Aug 11, 2011 Quarterly Results -
Apr 27, 2011 Quarterly Results -
Feb 28, 2011 Audited Results & Final Dividend -
Dec 21, 2010 Quarterly Results -
Nov 24, 2010 To consider a proposal for Merger To consider a proposal for Merger of Solvay Pharma India Ltd. with the Company in terms of the provisions of Sections 391 to 394 of the Companies Act, 1956.
Sep 28, 2010 Quarterly Results -
Jun 29, 2010 Quarterly Results & Others To change the accounting year of the Co. from Dec 01 - Nov 30 to the calendar year Jan 01 - Dec 31 therefore, The statutory books of accounts of the Co. prepared for a period of 13 months.
Mar 30, 2010 Quarterly Results -
Feb 01, 2010 Audited Results & Dividend -
Sep 29, 2009 Quarterly Results -
Jun 24, 2009 Quarterly Results -
Mar 30, 2009 Quarterly Results -
Jan 28, 2009 Audited Results & Dividend -
Sep 23, 2008 Quarterly Results -
Jun 20, 2008 Quarterly Results -
Mar 28, 2008 Quarterly Results -
Feb 14, 2008 Audited Results & Dividend -
Sep 30, 2007 Quarterly Results (Revised)
Sep 05, 2007 Buy Back of Shares To consider a proposal for buyback of a portion of fully paid equity shares of the Company at a price to be determined by the Board, which will not exceed Rs 650/- per equity share.
Jun 21, 2007 Quarterly Results -
Feb 08, 2007 Accounts & Dividend -
Sep 18, 2006 Quarterly Results -
Aug 25, 2006 Buy Back of Shares -
Jun 29, 2006 Quarterly Results -
Mar 31, 2006 Quarterly Results -
Mar 07, 2006 Accounts & Dividend (Revised)
Sep 21, 2005 Quarterly Results -
Jun 28, 2005 Quarterly Results -
Mar 22, 2005 Quarterly Results -
Jan 25, 2005 Accounts & Dividend -
Sep 28, 2004 Quarterly Results -
Jun 28, 2004 Quarterly Results -
Mar 24, 2004 Quarterly Results -
Feb 25, 2004 Accounts & Dividend -
Oct 24, 2003 Quarterly Results & Others Amalgamation of Lenbrook Pharmaceuticals with the Company.
Sep 30, 2003 Quarterly Results -
Jun 18, 2003 Quarterly Results -
Mar 31, 2003 Quarterly Results -
Feb 21, 2003 Dividend & Accounts -
Sep 25, 2002 Quarterly Results -
Jun 27, 2002 Quarterly Results -
Mar 27, 2002 Quarterly Results -
Feb 27, 2002 Accounts, Dividend(11 months) & Others Accounts & Dividend(11 months)and buy back of equity shares and Sale of company's undertaking at E-1, MIDC Industrial Area, Jejuri 412303.
Oct 23, 2001 Quarterly Results -
Jul 16, 2001 Quarterly Results -
Apr 30, 2001 Quarterly Results -
Feb 22, 2001 Accounts -
Oct 31, 2000 Quarterly Results -
Jul 28, 2000 Quarterly Results -
Apr 27, 2000 Interim Dividend -
Apr 12, 2000 Interim Dividend (Revised) -
Mar 10, 2000 Accounts & Dividend. -
Oct 28, 1999 Quarterly Results -
Jul 27, 1999 Quarterly Results -
Jul 26, 1999 Quarterly Results (Revised) -
Apr 28, 1999 Quarterly Results -
Feb 23, 1999 Accounts & Dividend -
Oct 07, 1998 Quarterly Results -
May 06, 1998 Bonus issue -
Mar 30, 1998 Accounts & Dividend -
Mar 25, 1997 Accounts & Dividend -
Ex-Date Bonus Ratio Record Date
Bigul
28 Jun 2024

ABBOTT INDIA LTD. - 500488 - Intimation Under Regulation 30

 Intimation under Regulation 30
Bigul
26 Jun 2024

ABBOTT INDIA LTD. - 500488 - Closure of Trading Window

 Closure of Trading Window
Bigul
13 Jun 2024

ABBOTT INDIA LTD. - 500488 - Announcement under Regulation 30 (LODR)-Resignation of Director

 Resignation Letter of Non-Executive Director.
Bigul
12 Jun 2024

ABBOTT INDIA LTD. - 500488 - Announcement under Regulation 30 (LODR)-Change in Directorate

 Appointment of Additional Non-Executive Director
Bigul
11 Jun 2024

ABBOTT INDIA LTD. - 500488 - Announcement under Regulation 30 (LODR)-Resignation of Director

 Resignation of Director
Bigul
06 Jun 2024

ABBOTT INDIA LTD. - 500488 - Announcement under Regulation 30 (LODR)-Change in Management

 We refer to our earlier communication dated March 15, 2024, please find attached the resignation letter of Senior Management Personnel.
Bigul
30 May 2024

ABBOTT INDIA LTD. - 500488 - Communication To Shareholders: Intimation About Tax Deduction At Source On Dividend

 Communication to Shareholders : Intimation about Tax Deduction at Source on Dividend.
19 May 2024

Abbott India eyes 45% female representation in management team, 1 lakh youths in STEM programmes by 2030

 Addressing the global STEM worker shortage, Abbott plans to create opportunities for over 1,00,000 youths, including 50% from underrepresented groups, to participate in STEM programmes and internships by 2030.
Bigul
10 May 2024

ABBOTT INDIA LTD. - 500488 - Newspaper Publication

 Newspaper Publication
10 May 2024

Abbott India Q4 Results Review - Highest-Ever Ebitda Margins: Axis Securities

 The company's gross margins improved by 57 bps YoY due to changes in product mix and a fall in raw material prices.
See all News

FAQs

The latest market price of Abbott India Ltd. on NSE was Rs. 27768.10 as of today.

The opening share price of Abbott India Ltd. was Rs. 27700.00 as of today.

The 52-week high share price of Abbott India Ltd. was Rs. 29639.00.

The 52 week low share price of Abbott India Ltd. was Rs. 22000.00.

Abbott India Ltd. has a market cap of Rs. 59005.30 crore as of today. Please refer to the Fundamentals section for further details.

The PE ratio of Abbott India Ltd. is 1.90. Please refer to the Fundamentals section for further details.

The operating revenue for Abbott India Ltd. in the last FY was Rs.  5848.91 crore. Please refer to the Financials section for further details.

The Net Profit for Abbott India Ltd. in the last FY was Rs. 1201.22 crore. Please refer to the Financials section for further details.

Please refer to Stock Ants, Bigul’s Community Access platform that aggregates tips and research from experts and provides real-time tracking to help investors validate, discover new investment ideas, and make informed decisions. Click here to learn more.

Please refer to Stock Ants, Bigul’s Community Access platform that aggregates tips and research from experts and provides real-time tracking to help investors validate, discover new investment ideas, and make informed decisions. Click here to learn more.

The latest dividend declared by Abbott India Ltd. was on 2023-07-21 for Rs. 145 per share. According to today’s share price, the dividend yield of Abbott India Ltd. stands at 1.20. Please refer to the Corporate Actions section for further details.

Please find Corporate actions section for more details.

Please find Corporate actions section for more details.

Please refer to Bigul Traders Corner, One Stop destination for different algo and non-algo trading strategies and tools meant for investors, traders, and strategists. Our qualified experts with rich experience in broking, financial analysis, and software development designed it in-house. Click here to learn more.

Please refer to JARVIS, which is Bigul’s AI Portfolio Manager Tool that uses artificial intelligence algorithms to make investment decisions in a portfolio. Click here to learn more.

Please refer to the News section for the latest news about Abbott India Ltd..

Close

Let's Open Free Demat Account